AUTOSOMAL DOMINANT HYPOCALCEMIA TYPE 1 (ADH1)

Clinical trials for AUTOSOMAL DOMINANT HYPOCALCEMIA TYPE 1 (ADH1) explained in plain language.

Never miss a new study

Get alerted when new AUTOSOMAL DOMINANT HYPOCALCEMIA TYPE 1 (ADH1) trials appear

Sign up with your email to follow new studies for AUTOSOMAL DOMINANT HYPOCALCEMIA TYPE 1 (ADH1), keep track of the ones that matter, and come back to a personal dashboard instead of checking manually.

Our safety recommendation!

By submitting, you agree to our Terms of use

Trials to join now! 1 Completed 1

New hope for kids with rare calcium disease

Disease control Recruiting now

This study is testing a drug called encaleret in children from birth to age 17 who have a rare inherited condition called Autosomal Dominant Hypocalcemia Type 1 (ADH1). ADH1 causes low blood calcium and related health problems. The main goals are to see how the child's body proce…

Matched conditions: AUTOSOMAL DOMINANT HYPOCALCEMIA TYPE 1 (ADH1)

Phase: PHASE2, PHASE3 • Sponsor: Calcilytix Therapeutics, Inc., a BridgeBio company • Aim: Disease control

Last updated Mar 18, 2026 18:25 UTC

AUTOSOMAL DOMINANT HYPOCALCEMIA TYPE 1 (ADH1)

Get alerted when new AUTOSOMAL DOMINANT HYPOCALCEMIA TYPE 1 (ADH1) trials appear

New hope for kids with rare calcium disease